The results of the present study are in consonance with a recent clinical report by Li et al. Their study also suggested that berberine may improve negative symptoms in patients with schizophrenia via anti-inflammatory action as the negative symptoms improvements coincided with significant decrease in serum inflammatory markers including IL-6 and C-creative protein [31]. This evidence concerns the gene IL6 and schizophrenia.